This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011) | MicrobiomeTrials
← Back to trials NCT06651281
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011) Recruiting PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2024-11-25Est. Completion: 2037-12-17
Enrollment target: 1,380 participantsLocations Connecticut Clinical Research Institute ( Site 0297), Bristol, Connecticut, United States St. Joseph Mercy Hospital - Huron Gastroenterology Associates ( Site 0287), Ypsilanti, Michigan, United States BVL Research - Kansas ( Site 0292), Liberty, Missouri, United States New York Gastroenterology Associates ( Site 0253), New York, New York, United States GI Alliance - Digestive Health Associates of Texas - DHAT ( Site 0290), Garland, Texas, United States GI Alliance - Lubbock ( Site 0288), Lubbock, Texas, United States Caprock Gastro Research ( Site 0293), Lubbock, Texas, United States Southern Star Research Institute ( Site 0299), San Antonio, Texas, United States GI Alliance - Southlake ( Site 0298), Southlake, Texas, United States Tyler Research Institute ( Site 0294), Tyler, Texas, United States University of Virginia Health System ( Site 0291), Charlottesville, Virginia, United States Washington Gastroenterology - Tacoma ( Site 0295), Tacoma, Washington, United States Vojenská Nemocnice Brno-Internal department ( Site 0701), Brno, Brno-mesto, Czechia Hepato-Gastroenterologie HK ( Site 0700), Hradec Králové, Czechia Other microbiome trials you might be interested in Inflammatory Bowel Disease Crohn's Disease Ulcerative Colitis
Background:
Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …
Bethesda, United States Est. completion Jun 1, 2036
Inflammatory Bowel Disease (IBD)
This observational study will use intestinal ultrasound images to help develop computer programs that may make it easier…
Vancouver, Canada Est. completion Feb 1, 2027
Centre Hospitalier Universitaire de Nice - Hôpital l'Archet ( Site 1002), Nice, Alpes-Maritimes, France
CMC Ambroise Paré Hartmann - Institut des MICI ( Site 1003), Neuilly-sur-Seine, Hauts-de-Seine, France
CHRU De Nancy - Hopital de Brabois ( Site 1001), Vandœuvre-lès-Nancy, Meurthe-et-Moselle, France
Hopital Claude Huriez CHRU LILLE ( Site 1004), Lille, Nord, France
ARENSIA Exploratory Medicine Georgia ( Site 1104), Tbilisi, Georgia
Békés Megyei Központi Kórház Dr. Réthy Pál Tagkórház-4. Belgyogyaszat Gasztroenterologia ( Site 1411), Békéscsaba, Bekes County, Hungary
Semmelweis Egyetem ( Site 1400), Budapest, Hungary
Rivermed Sp. z.o.o. ( Site 2206), Poznan, Greater Poland Voivodeship, Poland
Centrum Diagnostyczno - Lecznicze Barska sp. z o.o. ( Site 2208), Włocławek, Kuyavian-Pomeranian Voivodeship, Poland
Krakowskie Centrum Medyczne ( Site 2210), Krakow, Lesser Poland Voivodeship, Poland
Centrum Medyczne Oporow ( Site 2212), Wroclaw, Lower Silesian Voivodeship, Poland
Melita Medical Sp. z o.o. ( Site 2204), Wroclaw, Lower Silesian Voivodeship, Poland
Przychodnia Futuremeds Wroclaw ( Site 2211), Wroclaw, Lower Silesian Voivodeship, Poland
1 Wojskowy Szpital Kliniczny Z Poliklinika SPZOZ w Lublinie ( Site 2205), Lublin, Lublin Voivodeship, Poland
Medrise Sp. z o.o. ( Site 2200), Lublin, Lublin Voivodeship, Poland
EB Group Sp. Z o.o. Centrum Zdrowia MDM ( Site 2202), Warsaw, Masovian Voivodeship, Poland
Vivamed Sp. z o.o. ( Site 2201), Warsaw, Masovian Voivodeship, Poland
WIP Warsaw IBD Point Professor Kierkus ( Site 2209), Warsaw, Masovian Voivodeship, Poland
Vita Longa Sp. Zoo ( Site 2213), Katowice, Silesian Voivodeship, Poland
Sonomed Sp. z o. o. ( Site 2203), Szczecin, West Pomeranian Voivodeship, Poland
Bonifraterskie Centrum Medyczne ( Site 2207), Lodz, Łódź Voivodeship, Poland
Whipps Cross University Hospital ( Site 3400), London, England, United Kingdom
MAC Research - Merseyside ( Site 3401), Prescot, Knowsley, United Kingdom Phase 3
Completed
This is a multicenter, randomized, placebo controlled study to evaluate the efficacy and safety of ABX464 given at 25 or…
Dothan, United States Completed Jun 24, 2025